IP Library Granted Patent US 11,844,923
Granted Patent B2
US 11,844,923 · App. 17/443,130 · Granted Dec 19, 2023

Devices, systems, and methods for estimating active medication from injections

Inventors: John Sjolund (Los Altos, CA); Ambika Srinath (San Francisco, CA); Andrew Bochenko (Redwood City, CA); George Crothall (Oceanside, CA); Bryan Mazlish (Palo Alto, CA); Jennifer Martin Block (Menlo Park, CA); Sarah Matarese (San Jose, CA); Linda Mackowiak (Cazenovia, NY); Lane Desborough (Thousand Oaks, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/003A61B5/0004A61B5/14532A61B5/4839A61B5/7405A61B5/746A61B5/7435A61B5/7455A61M5/3202A61M2005/2006A61M2205/3306A61M2205/3584A61M2205/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,844,923
App. No.
17/443,130
Granted
Dec 19, 2023
Kind
B2
Abstract

One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.

Claims (39)

1. A diabetes therapy management system, comprising

a mobile computing device configured to receive one or more user-specific dosage parameters or predetermined doses from a user;

a glucose sensor system configured to collect and wirelessly transmit glucose measurement data; and

a reusable accessory reversibly attachable to a medication injection pen, the reusable accessory comprising:

a wireless communication interface;

an injection detection mechanism;

a display; and

at least one processor; and

at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the reusable accessory to:

receive the glucose measurement data from the glucose sensor system via the wireless communication interface;

receive the one or more user-specific dosage parameters or predetermined doses from the mobile computing device via the wireless communication interface;

detect an event associated with an injection of medication from the medication injection pen via an injection detection mechanism;

determine a percentage of medication from the injection of medication that remains active; and

cause the display to display an amount of active medication remaining in the user as a percentage of the injection of medication.

2. The system of claim 1 , wherein the reusable accessory comprises instruction that, when executed by the at least one processor, cause the reusable accessory to:

detect or determine a dose of medication for each event associated with an injection of medication; and

cause the display to display an amount of active medication remaining in the user as a number of units of medication.

3. The system of claim 1 , wherein the reusable accessory comprises instruction that, when executed by the at least one processor, cause the reusable accessory to: not detect or determine a dose of medication for each event associated with an injection of medication.

4. The system of claim 1 , wherein the glucose measurement comprises an interstitial fluid glucose level or data based on an interstitial fluid glucose level.

5. The system of claim 1 , wherein the glucose measurement comprises a blood glucose level correlated to an interstitial fluid glucose level.

6. The system of claim 1 , wherein the glucose measurement comprises a blood glucose level.

7. A reusable accessory reversibly attachable to a medication injection pen, the reusable accessory configured to:

detect an event associated with an injection of medication via the medication injection pen; and

determine a value that represents a percentage of medication from the injection of medication that remains active within a user based at least partially on the detected event associated with the injection of medication.

8. The reusable accessory of claim 7 , wherein the reusable accessory comprises a replacement pen cap securable to the medication injection pen.

9. The reusable accessory of claim 8 , wherein detecting an event associated with an injection of medication from the medication injection pen comprises detecting capping or decapping the medication injection pen with the replacement pen cap.

10. The reusable accessory of claim 7 , comprising a display, wherein the reusable accessory is configured to display a visual indicator of the percentage of medication that remains active within the user.

11. The reusable accessory of claim 7 , wherein the reusable accessory is configured to determine dose amounts for a plurality of detected events associated with a plurality of injections of medication.

12. The reusable accessory of claim 11 , wherein the reusable accessory is configured to determine an amount of medication from each of the plurality of injections of medication that remains active within the user based at least partially on the plurality of injections of medication.

13. The reusable accessory of claim 7 , wherein the reusable accessory is configured to not detect or determine a dose amount for the detected event associated with the injection of medication.

14. The reusable accessory of claim 7 , wherein the medication injection pen comprises an insulin injection pen.

15. The reusable accessory of claim 7 , wherein the reusable accessory is configured to determine a recommended dose of medication based at least in partially on both of user-specific dosage parameters and the determination of the percentage of medication that remains active within the user.

16. The reusable accessory of claim 7 , wherein the reusable accessory is configured to send data regarding the detected event associated with the injection of medication to a mobile computing device.

17. The reusable accessory of claim 16 , wherein the reusable accessory is configured to receive user-specific dosage parameters from the mobile computing device.

18. A method of managing a diabetes therapy, comprising:

detecting an event associated with an injection of medication from a medication injection pen; and

determining a value representing a percentage of medication from the injection of medication that remains active within a user based at least partially on the injection of medication.

19. The method of claim 18 , wherein detecting the event associated with the injection of medication from the medication injection pen is performed responsive to attaching or detaching a reusable accessory to the medication injection pen.

20. The method of claim 18 , wherein determining the percentage of medication from the injection of medication that remains active within the user comprises determining the percentage of medication from the injection of medication that remains active within the user based on a current time and a time of the detected event associated with the injection of medication.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2024
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA; DESBOROUGH, LANE
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068572/0468 →
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068948/0377 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
Cited By (3)
US 12,207,952 US 12,616,426 US 12,629,106